Quality of life assessment during cancer treatment helps owners and veterinarians make welfare-centered decisions about continuing, modifying, or discontinuing treatment.
Cancer treatment decisions in dogs should be guided by quality of life assessment rather than tumor response alone. A dog achieving partial tumor response but with significantly reduced quality of life from treatment toxicity is not experiencing welfare benefit from that treatment. Conversely, a dog in stable disease with good quality of life is experiencing welfare benefit from treatment even without complete response. The integration of owner-reported quality of life data alongside clinical measures provides a more complete welfare picture for guiding treatment decisions throughout the cancer journey.